Cara Therapeutics Ord Shs (CARA)
$17.63 0.00 (0.00%)
17:25 EDT CARA Stock Quote Delayed 30 Minutes
Previous Close $17.63
Market Cap 597.21M
PE Ratio -11.30
Volume (Avg. Vol.)
Day's Range 17.63 - 17.63
52-Week Range 8.88 - 27.55
Dividend & Yield N/A (N/A)
CARA Stock Predictions, Articles, and Cara Therapeutics Ord Shs News
- From InvestorPlace
- From the Web
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.
Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock
Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.
Cara Therapeutics (CARA) shares were up more than 11% on Wednesday as the company received good news regarding its latest clinical trial.
3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)
Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.
Why Best Buy Co Inc (BBY), Abercrombie & Fitch Co. (ANF) and Cara Therapeutics Inc (CARA) Are 3 of Today’s Worst Stocks
Too bad for Cara Therapeutics (CARA), Abercrombie & Fitch (ANF) and Best Buy (BBY) owners -- the market doesn't do do-overs.
Why Pandora Media Inc (P), Cara Therapeutics Inc (CARA) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks
Micron Technology (MU), Pandora (P) and Cara Therapeutics (CARA) all ended the trading week on a bearish foot, but for understandable reasons.
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Cara Therapeutics (CARA) stock was flying high on Friday following good news from the U.S. Food and Drug Administration.
Why Sears Holdings Corp (SHLD), Cara Therapeutics Inc (CARA) and Exxon Mobil Corporation (XOM) Are 3 of Today’s Worst Stocks
Cara Therapeutics (CARA), Sears Holdings (SHLD) and Exxon Mobil (XOM) and the day and the week on a low note, though for understandable reasons.
Kulicke and Soffa Industries (KLIC +3.7%) increases its share repurchase program by $100M to $400M and also extends its term for two more years through August 1, 2022.Through 3Q ended June, the company has repurchased 11.1M shares worth $249.1M under this program, initiated in August 2017.The new authorization is effective immediately and may be suspended or discontinued at any time.Previously: Kulicke & Soffa adds $100M to share repurchase program (Feb.
Should You Take Comfort From Insider Transactions At Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC)?
We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The flip side of that is that there are more<div><a class="permalink" href="https://simplywall.st/stocks/us/semiconductors/nasdaq-klic/kulicke-and-soffa-industries/news/should-you-take-comfort-from-insider-transactions-at-kulicke-and-soffa-industries-inc-nasdaqklic/">Read More...</a></div>
Why You Should Leave Kulicke and Soffa Industries, Inc.’s (NASDAQ:KLIC) Upcoming Dividend On The Shelf
Readers hoping to buy Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. Investors can<div><a class="permalink" href="https://simplywall.st/stocks/us/semiconductors/nasdaq-klic/kulicke-and-soffa-industries/news/why-you-should-leave-kulicke-and-soffa-industries-inc-s-nasdaqklic-upcoming-dividend-on-the-shelf/">Read More...</a></div>
Legendary fund manager Li Lu (who Charlie Munger backed) once said, ‘The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of<div><a class="permalink" href="https://simplywall.st/stocks/us/semiconductors/nasdaq-klic/kulicke-and-soffa-industries/news/is-kulicke-and-soffa-industries-nasdaqklic-using-too-much-debt/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader